Leerink Partners Remains Bullish on Aquinox Pharma (AQXP) Following Investor Day
Tweet Send to a Friend
Leerink Partners reiterated an Outperform rating and $26.00 price target on Aquinox Pharmaceutical (NASDAQ: AQXP) after attending an investor day ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
